Trial Profile
Relevance of Valganciclovir in Recurrent Bouts of Cryptogenic Inflammatory Bowel Diseases With an Infection by Cytomegalovirus.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Valganciclovir (Primary)
- Indications Inflammatory bowel diseases
- Focus Therapeutic Use
- 03 Apr 2009 New trial record